Promising therapy for fatty liver disease reduces fat, inflammation, and scarring in preclinical models - Medical Xpress
MedicalxpressSeptember 29, 2026

For millions of people living with metabolic dysfunction-associated steatohepatitis (MASH), treatment options remain limited. The progressive form of fatty liver disease develops when excess fat accumulates in the liver, leading to inflammation, tissue damage…
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our United States coverage. We hold 1047 health stories in total, and 29 from Medicalxpress.
This is a summary of reporting by Medicalxpress. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.
